Results 291 to 300 of about 1,407,327 (308)

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Lancet, The, 2010
Paul Y Kwo, John M Vierling
exaly  

Serine Protease Mechanism and Specificity

Chemical Reviews, 2002
Lizbeth Hedstrom
exaly  

Proteases

Current Biology, 1992
Margaret A. Phillips, Robert J. Fletterick   +1 more
openaire   +1 more source

Severe premature coronary artery disease with protease inhibitors

Lancet, The, 1998
exaly  

Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents

Lancet, The, 2003
James M Oleske, Stephen A Spector
exaly  

Proteases

2005
M.R. Kanost, T.E. Clarke
openaire   +1 more source

Protease inhibitor-associated hyperglycaemia

Lancet, The, 1997
exaly  

Benign symmetric lipomatosis associated with protease inhibitors

Lancet, The, 1997
exaly  

A SUMO protease for stress protection

Nature Reviews Molecular Cell Biology, 2013
exaly  

Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities

Lancet, The, 1998
exaly